Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel

被引:328
作者
Sun, M [1 ]
Goldin, E
Stahl, S
Falardeau, JL
Kennedy, JC
Acierno, JS
Bove, C
Kaneski, CR
Nagle, J
Bromley, MC
Colman, M
Schiffmann, R
Slaugenhaupt, SA
机构
[1] NINDS, Dev & Metab Neurol Branch, NIH, Bethesda, MD 20892 USA
[2] NINDS, DNA Sequencing Facil, NIH, Bethesda, MD 20892 USA
[3] Harvard Univ, Sch Med, Harvard Inst Human Genet, Boston, MA 02115 USA
[4] Massachusetts Gen Hosp, Mol Neurogenet Unit, Charlestown, MA USA
关键词
D O I
10.1093/hmg/9.17.2471
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mucolipidosis type IV (MLIV) is a developmental neurodegenerative disorder characterized by severe neurologic and ophthalmologic abnormalities, The MLIV gene, ML4 (MCOLN1), has recently been localized to chromosome 19p13.2-13.3 by genetic linkage. Here we report the cloning of a novel transient receptor potential cation channel gene and show that this gene is mutated in patients with the disorder, ML4 encodes a protein, which we propose to call mucolipin, which has six predicted transmembrane domains and is a member of the polycystin II subfamily of the Drosophila transient receptor potential gene family. The role of a potential receptor-stimulated cation channel defect in the pathogenesis of mucolipidosis IV is discussed.
引用
收藏
页码:2471 / 2478
页数:8
相关论文
共 20 条
[1]  
Antonarakis SE, 1998, HUM MUTAT, V11, P1
[2]   Mucolipidosis type IV: Abnormal transport of lipids to lysosomes [J].
Bargal, R ;
Bach, G .
JOURNAL OF INHERITED METABOLIC DISEASE, 1997, 20 (05) :625-632
[3]   CONGENITAL CORNEAL CLOUDING WITH ABNORMAL SYSTEMIC STORAGE BODIES - NEW VARIANT OF MUCOLIPIDOSIS [J].
BERMAN, ER ;
LIVNI, N ;
SHAPIRA, E ;
MERIN, S ;
LEVIJ, IS .
JOURNAL OF PEDIATRICS, 1974, 84 (04) :519-526
[4]   MUCOLIPIDOSIS TYPE-IV - PRESENTATION OF A MILD VARIANT [J].
CASTEELS, I ;
TAYLOR, DSI ;
LAKE, BD ;
SPALTON, DJ ;
BACH, G .
OPHTHALMIC PAEDIATRICS AND GENETICS, 1992, 13 (04) :205-210
[5]   Compromised cytoarchitecture and polarized trafficking in autosomal dominant polycystic kidney disease cells [J].
Charron, AJ ;
Nakamura, S ;
Bacallao, R ;
Wandinger-Ness, A .
JOURNAL OF CELL BIOLOGY, 2000, 149 (01) :111-124
[6]   Abnormal transport along the lysosomal pathway in Mucolipidosis, type IV disease [J].
Chen, CS ;
Bach, G ;
Pagano, RE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) :6373-6378
[7]  
Foggensteiner L, 2000, J AM SOC NEPHROL, V11, P814, DOI 10.1681/ASN.V115814
[8]   MUCOLIPIDOSIS-IV - MORPHOLOGY AND HISTOCHEMISTRY OF AN AUTOPSY CASE [J].
FOLKERTH, RD ;
ALROY, J ;
LOMAKINA, I ;
SKUTELSKY, E ;
RAGHAVAN, SS ;
KOLODNY, EH .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1995, 54 (02) :154-164
[9]   Mucolipidosis type IV - Characteristic MRI findings [J].
Frei, KP ;
Patronas, NJ ;
Crutchfield, KE ;
Altarescu, G ;
Schiffmann, R .
NEUROLOGY, 1998, 51 (02) :565-569
[10]   Mucolipidosis IV consists of one complementation group [J].
Goldin, E ;
Cooney, A ;
Kaneski, CR ;
Brady, RO ;
Schiffmann, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (15) :8562-8566